GSK Executive Sells Shares on London Exchange

GlaxoSmithKline (GSK) has released an update.

GSK plc has reported a transaction involving the sale of 6,000 Ordinary Shares by Senior Vice President Sally Jackson on May 1, 2024. The shares were sold at a price of £17.0167 each on the London Stock Exchange. This initial notification is part of the company’s monthly update to the Securities Exchange Commission.

For further insights into GSK stock, check out TipRanks’ Stock Analysis page.